Skip to main content

Advertisement

SpringerLink
Log in

Acquired FXIII inhibitors: a systematic review

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Coagulation factor XIII (FXIII) is a protein that promotes fibrin stabilization by forming multiple covalent cross-links between fibrin monomers. Beside congenital FXIII deficiency, due to FXIII gene mutations, severe acquired FXIII deficiency has been described in association with autoantibodies against coagulation FXIII. These inhibitors, which occurs very rarely but may cause life-threatening bleeding complications, may arise spontaneously or in association with autoimmune and lymphoproliferative disorders or medications. The management of patients with acquired FXIII inhibitors is very demanding and treatment regimens must be focused on eradication of the inhibitor and to increase the plasma FXIII levels. In this systematic review, we analyse all the published case-reports on anti-FXIII autoantibodies focusing on the clinical features and treatment modalities of this acquired hemorrhagic condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lorand L, Losowsky MS, Miloszewski KJ (1980) Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb 5:245–290

    PubMed  CAS  Google Scholar 

  2. Schwartz ML, Pizzo SV, Hill RL, McKee PA (1973) Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 248:1395–1407

    PubMed  CAS  Google Scholar 

  3. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A (2003) Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 102:4410–4412

    Article  PubMed  CAS  Google Scholar 

  4. Takagi T, Doolittle RF (1974) Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 13:750–756

    Article  PubMed  CAS  Google Scholar 

  5. Ichinose A, Davie EW (1988) Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 85:5829–5833

    Article  PubMed  CAS  Google Scholar 

  6. Webb GC, Coggan M, Ichinose A, Board PG (1989) Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet 81:157–160

    Article  PubMed  CAS  Google Scholar 

  7. Board PG, Losowsky MS, Miloszewski KJA (1993) Factor XIII: inherited and acquired deficiency. Blood Rev 7:229–242

    Article  PubMed  CAS  Google Scholar 

  8. Hsieh L, Nugent D (2008) Factor XIII deficiency. Haemophilia 14:1190–1200

    Article  PubMed  CAS  Google Scholar 

  9. Karimi M, Bereczky Z, Cohan N, Muszbek L (2009) Factor XIII deficiency. Semin Thromb Hemost 35:426–438

    Article  PubMed  CAS  Google Scholar 

  10. Lorand L (2005) Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost 3:1337–1348

    Article  PubMed  CAS  Google Scholar 

  11. Ichinose A (2011) Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 37:382–388

    Article  PubMed  CAS  Google Scholar 

  12. Lewis JH, Szeto IL, Ellis LD, Bayer WL (1967) An acquired inhibitor to coagulation factor 13. Johns Hopkins Med J 120:401–407

    PubMed  CAS  Google Scholar 

  13. Lorand L, Jacobsen A, Bruner-Lorand J (1968) A pathological inhibitor of fibrin cross-linking. J Clin Investig 47:268–273

    Article  PubMed  CAS  Google Scholar 

  14. Godal HC (1970) An inhibitor to fibrin stabilizing factor (FSF, factor XIII). Scand J Haematol 7:43–48

    Article  PubMed  CAS  Google Scholar 

  15. Lorand L, Maldonado N, Fradera J, Atencio AC, Robertson B, Urayama T (1972) Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII). Br J Haematol 23:17–27

    Article  PubMed  CAS  Google Scholar 

  16. Lopaciuk S, Bykowska K, McDonagh JM et al (1978) Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder. J Clin Investig 61:1196–1203

    Article  PubMed  CAS  Google Scholar 

  17. McDevitt NB, McDonagh J, Taylor HL, Roberts HR (1972) An acquired inhibitor to factor XIII. Arch Intern Med 130:772–777

    Article  PubMed  CAS  Google Scholar 

  18. Graham JE, Yount WJ, Roberts HR (1973) Immunochemical characterization of a human antibody to factor XIII. Blood 41:661–669

    PubMed  CAS  Google Scholar 

  19. Otis PT, Feinstein DI, Rapaport SI, Patch MJ (1974) An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations. Blood 44:771–781

    PubMed  CAS  Google Scholar 

  20. Rosenberg RD, Colman RW, Lorand L (1974) A new haemorrhagic disorder with defective fibrin stabilization and cryofibrinogenaemia. Br J Haematol 26:269–284

    Article  PubMed  CAS  Google Scholar 

  21. Milner GR, Holt PJ, Bottomley J, Maciver JE (1977) Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII. J Clin Pathol 30:770–773

    Article  PubMed  CAS  Google Scholar 

  22. Shires L, Gomperts ED, Bradlow BA (1979) An acquired inhibitor to factor XIII A case report. S Afr Med J 56:70–72

    PubMed  CAS  Google Scholar 

  23. Fear JD, Miloszewski KJ, Losowsky MS (1984) An acquired inhibitor of factor XIII with a qualitative abnormality of fibrin crosslinking. Acta Haematol 71:304–309

    Article  PubMed  CAS  Google Scholar 

  24. Nakamura S, Kato A, Sakata Y, Aoki N (1988) Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide. Br J Haematol 68:313–319

    Article  PubMed  CAS  Google Scholar 

  25. Lorand L, Velasco PT, Rinne JR et al (1988) Autoimmune antibody (IgG Kansas) against the fibrin stabilizing (factor XIII) system. Proc Natl Acad Sci USA 85:232–236

    Article  PubMed  CAS  Google Scholar 

  26. Daly HM, Carson PJ, Smith JK (1991) Intracerebral haemorrhage due to acquired factor XIII inhibitor—successful response to factor XIII concentrate. Blood Coagul Fibrinolysis 2:507–514

    Article  PubMed  CAS  Google Scholar 

  27. Krumdieck R, Shaw DR, Huang ST, Poon MC, Rustagi PK (1991) Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenstrom’s macroglobulinemia. Am J Med 90:639–645

    PubMed  CAS  Google Scholar 

  28. Gailani D (1992) An IgG inhibitor against coagulation factor XIII: resolution of bleeding after plasma immunoadsorption with staphylococcal protein A. Am J Med 92:110–112

    Article  PubMed  CAS  Google Scholar 

  29. Fukue H, Anderson K, McPhedran P, Clyne L, McDonagh J (1992) A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA. Blood 79:65–74

    PubMed  CAS  Google Scholar 

  30. Tosetto A, Rodeghiero F, Gatto E, Manotti C, Poli T (1995) An acquired hemorrhagic disorder of fibrin crosslinking due to IgG antibodies to FXIII, successfully treated with FXIII replacement and cyclophosphamide. Am J Hematol 48:34–39

    Article  PubMed  CAS  Google Scholar 

  31. Ahmad F, Solymoss S, Poon MC, Berube C, Sullivan AK (1996) Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus. Br J Haematol 93:700–703

    Article  PubMed  CAS  Google Scholar 

  32. Lorand L, Velasco PT, Murthy SN, Lefebvre P, Green D (1999) Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner. Blood 93:909–917

    PubMed  CAS  Google Scholar 

  33. Lorand L, Velasco PT, Hill JM, Hoffmeister KJ, Kaye FJ (2002) Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against factor XIII. Thromb Haemost 88:919–923

    PubMed  CAS  Google Scholar 

  34. Lim W, Moffat K, Hayward CPM (2004) Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency. J Thromb Haemost 2:1017–1019

    Article  PubMed  CAS  Google Scholar 

  35. Miesbach W (2005) Rituximab in the treatment of factor XIII inhibitor possibly caused by ciprofloxacin. Thromb Haemost 93:1001–1003

    PubMed  CAS  Google Scholar 

  36. Gregory TF, Cooper B (2006) Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent) 19:221–223

    Google Scholar 

  37. Ajzner E, Schlammadinger A, Kerényi A et al (2009) Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 113:723–725

    Article  PubMed  CAS  Google Scholar 

  38. Ishida F, Okubo K, Ito T, Okumura N, Souri M, Ichinose A (2010) Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency. Thromb Haemost 104:1284–1285

    Article  PubMed  CAS  Google Scholar 

  39. Luo Y, Zhang G, Zuo W, Zheng W, Dai C (2010) Acquired factor XIII inhibitor in monoclonal gammopathy of undetermined significance: characterization and cross-linked fibrin ultrastructure. Ann Hematol 89:833–834

    Article  PubMed  Google Scholar 

  40. Luo Y, Zhang G (2011) Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination. Haemophilia 17:393–398

    Article  PubMed  Google Scholar 

  41. Hayashi T, Kadohira Y, Morishita E, Asakura H, Souri M, Ichinose (2012) A case of acquired FXIII deficiency with severe bleeding symptoms. Haemophilia 18:618–620

    Article  PubMed  CAS  Google Scholar 

  42. Ichinose A, Souri M, Japanese collaborative research group on “Acquired haemorrha-philia due to factor XIII deficiency” (2011) As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan. Thromb Haemost 105:925–927

    Article  PubMed  CAS  Google Scholar 

  43. Tosetto A, Castaman G, Rodeghiero F (1993) Acquired plasma factor XIII deficiencies. Haematologica 78(Suppl. 6):5–10

    PubMed  CAS  Google Scholar 

  44. Franchini M, Lippi G, Favaloro EJ (2012) Acquired inhibitors of coagulation factors: part II. Semin Thromb Hemost 38:447–453

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy

    Massimo Franchini, Francesco Frattini, Silvia Crestani & Carlo Bonfanti

Authors
  1. Massimo Franchini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Frattini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvia Crestani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlo Bonfanti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Franchini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franchini, M., Frattini, F., Crestani, S. et al. Acquired FXIII inhibitors: a systematic review. J Thromb Thrombolysis 36, 109–114 (2013). https://doi.org/10.1007/s11239-012-0818-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0818-3

Keywords

Search

Navigation